
CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 35.62
2025-10-27 17:55:01CSPC Innovation Pharmaceutical Co., Ltd. faced notable volatility on October 24, 2025, with a significant stock decline. Over the past week and month, the stock has dropped considerably, while the company has reported negative results for six consecutive quarters, raising concerns about its long-term growth metrics and profitability.
Read More
CSPC Innovation Stock Hits Day Low of CNY 40.55 Amid Price Pressure
2025-10-23 17:49:29CSPC Innovation Pharmaceutical Co., Ltd. saw a notable stock decline, contrasting with the broader market's gains. The company has faced ongoing financial challenges, including significant drops in net sales and profits over recent quarters, raising concerns about its stability despite a strong year-to-date performance.
Read More
CSPC Innovation Stock Hits Day Low Amid Price Pressure at CNY 41.87
2025-10-15 17:50:58CSPC Innovation Pharmaceutical Co., Ltd. saw a significant stock decline today, contrasting with the minor decrease in the China Shanghai Composite. The company has faced a notable downturn over the past week and month, with ongoing financial challenges reflected in negative sales and profit metrics.
Read More
CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 45.88
2025-10-01 17:12:27CSPC Innovation Pharmaceutical Co., Ltd. saw a significant stock decline today, contrasting with the Shanghai Composite's modest gain. The company has faced a notable downturn over the past week and month, despite impressive annual growth. However, it has reported negative results for six consecutive quarters, raising concerns about its financial stability.
Read More
CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 47.38
2025-09-29 15:26:21CSPC Innovation Pharmaceutical Co., Ltd. experienced notable stock volatility on September 26, 2025, with a significant decline for the day. Despite a strong annual return, the company has faced ongoing challenges, including negative results over the last six quarters and a decline in key financial metrics. Its market capitalization is CNY 62,266 million.
Read More





